Mannatech (NASDAQ:MTEX) Releases Earnings Results

Mannatech (NASDAQ:MTEX) announced its quarterly earnings data on Wednesday. The company reported $0.53 earnings per share for the quarter, FiscalAI reports. The company had revenue of $26.65 million during the quarter. Mannatech had a negative return on equity of 2,383.34% and a negative net margin of 6.90%.

Mannatech Stock Down 12.0%

Shares of MTEX traded down $0.74 during mid-day trading on Friday, hitting $5.41. 2,148 shares of the company’s stock were exchanged, compared to its average volume of 22,134. The firm has a market cap of $10.44 million, a price-to-earnings ratio of -1.38 and a beta of 0.73. The stock’s 50-day simple moving average is $5.08 and its 200-day simple moving average is $5.73. Mannatech has a 52 week low of $3.80 and a 52 week high of $12.45.

Insider Buying and Selling at Mannatech

In other Mannatech news, Director Kevin Andrew Robbins purchased 7,100 shares of the company’s stock in a transaction dated Tuesday, May 19th. The stock was purchased at an average price of $4.17 per share, with a total value of $29,607.00. Following the completion of the purchase, the director owned 33,333 shares of the company’s stock, valued at approximately $138,998.61. The trade was a 27.07% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Insiders bought 14,903 shares of company stock worth $62,155 in the last quarter. Insiders own 47.50% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Weiss Ratings raised Mannatech from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday, August 6th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Mannatech has a consensus rating of “Sell”.

About Mannatech

Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.

The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.